Hosted on MSN

BD expands recall of its Alaris Pump Module model 8100

The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...
Nasdaq

BD Provides Update on Voluntary Recalls of Alaris(TM) Pump Module Model 8100 and Certain Alaris(TM) Pump Infusion Sets

FRANKLIN LAKES, N.J., July 18, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls ...
FierceBiotech

FDA doles out Class I rating to recall of replacement part for BD's Alaris infusion pump

A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.
Monthly Prescribing Reference

Compatibility Issues Prompt Recall of Alaris Infusion Pumps

To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...